64/100B39.440
USD
-0.54
(-1.35%)
Market Closed
Last updated: · Delayed 15 min
Medline revenue 2022–2026What is revenue? Revenue is the money a company brings in from selling its goods and services over a period, before any costs. It is the top line of the income statement.
Medline's revenue in Q3 FY2026, the three months to 26 September 2026, was 7.86B USD, up 10.4% on the same quarter a year before. Medline's revenue in fiscal year 2025 was 28.43B USD, up 11.5% on the year before.
Last updated 9 Nov 2026 · Next report 24 Feb 2027
Revenue
Growth
| Fiscal year | Period ending | Revenue | Growth | Gross profit | Net income |
|---|---|---|---|---|---|
| TTM | 26 Sept 2026 | 30.68B | — | 7.72B | 564.00M |
| FY2025 | 31 Dec 2025 | 28.43B | +11.47% | 7.52B | 1.16B |
| FY2024 | 31 Dec 2024 | 25.51B | +9.80% | 6.29B | 1.20B |
| FY2023 | 31 Dec 2023 | 23.23B | +8.31% | 5.22B | 234.00M |
| FY2022 | 31 Dec 2022 | 21.45B | — | 4.56B | -25.00M |
| Quarter | Period ending | Revenue | Growth on a year before | Gross profit | Net income |
|---|---|---|---|---|---|
| Q3 FY2026 | 26 Sept 2026 | 7.86B | +10.41% | 1.93B | 195.00M |
| Q2 FY2026 | 27 Jun 2026 | 7.69B | +11.60% | 2.22B | 60.00M |
| Q1 FY2026 | 31 Mar 2026 | 7.35B | +10.66% | 1.67B | 129.00M |
| Q4 FY2025 | 31 Dec 2025 | 7.79B | — | 1.91B | 180.00M |
| Q3 FY2025 | 30 Sept 2025 | 7.12B | +11.38% | 1.70B | 322.00M |
| Q2 FY2025 | 30 Jun 2025 | 6.89B | +11.33% | 1.73B | 333.00M |
| Q1 FY2025 | 31 Mar 2025 | 6.64B | — | 1.65B | 322.00M |
| Q3 FY2024 | 30 Sept 2024 | 6.39B | — | 1.58B | 324.00M |
| Q2 FY2024 | 30 Jun 2024 | 6.19B | — | 1.49B | 292.00M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
Medline revenue by segment over time
See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement
Common questions about Medline's revenue
Source: Financial Modeling Prep